SCHEMBL15213329

SCHEMBL15213329

COC(=O)[C@@H]1C[C@@H](Oc2nccc3cc(OC)c(Br)cc23)CN1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 16/20 0.40
APAF1 O14727 1/20 0.39
TDP2 O95551 1/20 0.39
NSD2 O96028 1/20 0.39
CASP3 P42574 1/20 0.39
PPP1CA P62136 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
SAE1 Q9UBE0 1/20 0.39
UBA2 Q9UBT2 1/20 0.39
PIM1 P11309 1/20 0.38
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL763152 0.91 IRAK4 (0.40) IRAK4APAF1TDP2NSD2CASP3
Hydrochloric Acid SCHEMBL2894708 0.90 IRAK4 (0.41) IRAK4APAF1TDP2NSD2CASP3
Hydrochloric Acid SCHEMBL733600 0.90 IRAK4 (0.39) IRAK4APAF1TDP2NSD2CASP3
SCHEMBL8229174 0.86 IRAK4 (0.39) IRAK4PIM1
Hydrochloric Acid SCHEMBL2430460 0.85 IRAK4 (0.39) IRAK4PIM1
SCHEMBL13433702 0.85 PIM1 (0.39) IRAK4PIM1
Hydrochloric Acid SCHEMBL3359714 0.84 PIM1 (0.39) IRAK4PIM1
SCHEMBL13066834 0.83 TRPA1 (0.38) IRAK4APAF1TDP2NSD2CASP3
SCHEMBL749214 0.80 IRAK4 (0.40) IRAK4
SCHEMBL4756377 0.78 PIM1 (0.39) IRAK4PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2816054-A1 MACROCYCLIC COMPOUNDS FOR SUPPRESSING REPLICATION OF HEPATITIS C VIRUS GINKGO PHARMA CO., LTD. (CN) 2014-12-24 EP disclosed
WO-2013120371-A1 MACROCYCLIC COMPOUNDS FOR SUPPRESSING REPLICATION OF HEPATITIS C VIRUS 银杏树药业(苏州)有限公司 (CN) 2013-08-22 WO disclosed